Scientists have managed to work out how two chemotherapy drugs work to destroy pancreatic cancer cells.
Experts at Cancer Research UK's Cambridge Research Institute made the discovery using ABRAXANE and gemcitabine.
They found that by combining the treatments, this increased the amount of active gemcitabine, making it more effective at destroying the cancer cells.
Nearly 8,000 people are diagnosed with pancreatic cancer each year, and it is commonly known as one of the most aggressive.
Dr Julie Sharp, senior science information manager at Cancer Research UK, said that the research gives "fresh hope for new ways to treat pancreatic cancer in the future using drugs that are already at our fingertips".
"Survival from this disease is still poor, so new treatment approaches are urgently needed and Cancer Research UK is dedicated to improving the outlook for patients," she explained.
Pancreatic cancer is the fifth most common cause of death from cancer, and accounts for five per cent of all cases of the disease.